Alzheimer's brain comparison
Scientists have long assumed that amyloid brain plaques found in autopsies of Alzheimer's patients are harmful and cause Alzheimer's disease. But autopsies of people with no signs of mental impairment have also revealed brain plaques, challenging this theory.
Now, for the first time, researchers at Washington University in St. Louis have shown that brain plaques in apparently healthy individuals are associated with increased risk of diagnosis with Alzheimer's disease years later.
In two studies published this month in Archives of Neurology, scientists report that volunteers with brain plaques were more likely to have declining scores on annual cognitive tests, to show signs of shrinkage in a key brain area affected by Alzheimer's and to eventually be diagnosed with the disease.
"We don't have enough data yet to definitively say that people who scan positive for these brain plaques have presymptomatic Alzheimer's disease, but something is clearly going on that does not bode well for the health of their aging brains," says John C. Morris, the Harvey A. and Dorismae Hacker Friedman Distinguished Professor of Neurology and director of Washington University's Alzheimer's Disease Research Center (ADRC) and the Friedman Center for Aging.
Morris and others at the ADRC have previously found evidence that Alzheimer's disease harms the brain for years prior to typical diagnosis. They are pushing for earlier diagnosis as an essential step to successful treatment of Alzheimer's disease, but to do that they first have to seek earlier indicators of disease and then wait years to see if people with the indicators later develop symptomatic Alzheimer's.
According to Morris, the new papers are early and encouraging indicators that scientists are on track to pushing back the time at which diagnosis can be made.
"We only have a very small number of subjects to date, but what we're learning so far has been consistent with our predictions," he says.
The new studies were made possible by the development of an imaging agent, Pittsburgh Compound B (PiB), that lets scientists use positron emission tomography scans to detect amyloid plaques in living brains for the first time. Prior to PiB, clinicians could only verify the presence of brain plaques during autopsies. PiB scanning of ADRC research participants is directed by Mark Mintun, M.D., vice chair for research in radiology and professor of radiology at the University's Mallinckrodt Institute of Radiology.
Martha Storandt, Ph.D., professor of psychology and of neurology, led one of the studies, which compared a variety of factors in plaque-positive and plaque-negative subjects.
"One of the main things we wanted to know was whether people who scanned positive for brain plaques scored abnormally low on cognitive tests," she says. "They didn't, but when we looked at their annual testing records over a period of years, we saw that the scores of the plaque-positive group were declining, while those of the plaque-negative group were not."
Magnetic resonance imaging scans analyzed by Denise Head, Ph.D., assistant professor of psychology, revealed that brain areas hit hard by Alzheimer's disease, such as the parahippocampal gyrus, were smaller in subjects with plaques.
In a second study, led by Morris, researchers tracked a group of 159 volunteers, ages 51 to 88, who were scanned using PiB between 2004 and 2008. At the time of the scans, none of the participants showed signs of mental impairment. Twenty-three of the volunteers later developed mild impairment, and nine members of that group were diagnosed with Alzheimer's disease.
Those who stayed mentally healthy did not scan positive for plaques, but volunteers later diagnosed with problems did. Comparisons of the volumes of key brain structures revealed the same disparities seen in the other study: subjects who developed mental impairment had significant reductions in their parahippocampal gyrus and other structures affected by Alzheimer's.
According to Morris, a parallel effort at Washington University that analyzes cerebrospinal fluid to diagnose Alzheimer's earlier is also meeting with early success. That program is led by David Holtzman, M.D., the Andrew and Gretchen Jones Professor and chair of the Department of Neurology and Anne Fagan, Ph.D., research associate professor of neurology.
Morris speculates that earlier diagnosis and testing of new treatments may be possible within the next 10 years.
"There are risks inherent in Alzheimer's treatments, so we have to be careful that healthy people who are selected to receive these treatments to prevent dementia caused by Alzheimer's disease really do have presymptomatic disease," he says.
###
Washington University School of Medicine: http://www.medicine.wustl.edu Thanks to Washington University School of Medicine for this article.
This article has been viewed 806 time(s).
 |
 Digg |
 FarkIt |
 |
 StumbleUpon |
 del.icio.us |
 |
In 1824, three years before he began to publish his famous "double elephant folio" The Birds of America, John James Audubon (1785-1851), the eminent artist of American birds and animals, created a drawing of a running grouse for use in the design for a New Jersey bank note.
The recent discovery of more than a thousand genes known as large intergenic non-coding RNAs (or "lincRNAs") opened up a new approach to understanding the function and organization of the genome. That surprising breakthrough is now made even more compelling with the finding that dozens of these lincRNAs are induced by p53, the most commonly mutated gene in cancer
A genetics research team based at The Children's Hospital of Philadelphia continues to discover recurrent translocations—places in which two chromosomes exchange pieces of themselves. As many as 1 in 600 persons carry balanced chromosome translocations, which involve no loss or gain of DNA.
Some trees growing in nutrient-poor forest soil may get what they need by cultivating specific root microbes to create compounds they require. These microbes are exceptionally efficient at turning inorganic minerals into nutrients that the trees can use. Researchers from France report their findings in the July 2010 issue of the journal Applied and Environmental Microbiology.
"Macho, macho man. I've got to be, a macho man. Macho, macho man. I've got to be a macho!" — The Village People
"If one finds something once, it's accidental. If it is found twice, it's puzzling. If found thrice, there is a pattern," the archaeologists Olle Hemdorff and Eva Thäte say.
"In laboratory tests, right- and left-handers associate positive ideas like honesty and intelligence with their dominant side of space and negative ideas with their non-dominant side," says Daniel Casasanto of the Max Planck Institute for Psycholinguistics in Nijmegen, Netherlands.
Often causing no symptoms in carriers of the disease, worldwide tuberculosis (TB) infects eight to ten million people every year, kills two million, and it is highly contagious as it is spread through coughing and sneezing.